SMS Pharmaceuticals Ltd — Call Transcript 2024

May 31, 2024

==> picture [241 x 158] intentionally omitted <==

Date: 31[st] May, 2024

To, The Manager, Corporate Filings Department, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001

Security Code: 532815

The Manager, Listing Compliance Department, National Stock Exchange of India Ltd. Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051.

Symbol: SMSPHARMA

Dear Sir/Madam,

Sub: Audio recording of Analysts/Investors Conference Call pertaining to the Financial Results for the fourth quarter and financial year ended 31[st] March, 2024.

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, and further to our letter dated 27[th] May, 2023 regarding intimation of Investors/ Analyst conference call, held on today i.e., 31[st] May, 2023, on the Audited Financial Results of the Company for the fourth quarter and financial year ended 31[st] March, 2024, we would like to inform you that the audio recording of the said call made available on the Company’s website. This can be accessed via the following link.

https://smspharma.com/financials/audio-or-video-recording-of-investors-meet/

You are requested to take the same on record.

Thanking you

Yours Faithfully

For SMS Pharmaceuticals Limited

THIRUMALESH Digitally signed by THIRUMALESH TUMMA TUMMA Date: 2024.05.31 15:43:23 +05'30'

Thirumalesh Tumma Company Secretary